Click to enlarge
CIROFEM-D3 Oral Solution
CIROFEM-D3 Oral Solution
Back to products
SPIRABAG™ Tablets
SPIRABAG™ Tablets

Nitrofem Tablets

  • Contains Nitrofurantoin Sustained Release Tablets I.P. 100 mg, a urinary tract-specific antibacterial agent

  • Sustained release formulation ensures prolonged drug action and reduced dosing frequency

  • Each pack contains 10 x 10 tablets (100 tablets total) for extended treatment course and better compliance

  • Indicated for treatment and prevention of acute and recurrent uncomplicated urinary tract infections (UTIs)

  • Effective against susceptible gram-positive and gram-negative uropathogens including E. coli, Klebsiella, and Enterococcus

  • Achieves high urinary concentration with minimal systemic accumulation

  • Manufactured by FEMiNA under stringent quality standards

Category: Vendor: Bagrx
Description
Nitrofem | Nitrofurantoin Sustained Release Tablets I.P. 100 mg
– A sustained-release urinary antiseptic for effective UTI management. Provides prolonged antibacterial action with once or twice daily dosing. Supplied in a 10×10 tablet pack for reliable, long-term therapy.
Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Nitrofem Tablets”
Shipping & Delivery
Vendor Details

Vendor Information

Vendor: Bagrx

Related products

Quick view

BAGSURE-500 Injection

BAGSURE-500 is a sterile, ready-to-use intramuscular injection containing Hydroxyprogesterone Caproate I.P. 500 mg per 2 ml ampoule. Presented in a hospital-friendly Dispo Pack, it is indicated for supportive progesterone therapy in various gynecological and obstetric conditions. Manufactured by FEMiNA, this formulation ensures high purity, consistency, and reliable therapeutic outcomes.
Quick view

SPIRABAG™ Tablets

  • Contains Spiramycin Tablets I.P. 3 M.I.U. (3 Million I.U.) , a macrolide antibiotic with potent anti-infective and antiparasitic activity

  • Provides high tissue penetration and prolonged post-antibiotic effect

  • Each pack contains 10 x 1 x 10 tablets (100 tablets total) , ideal for complete treatment courses

  • Indicated for toxoplasmosis (including in pregnancy), respiratory tract infections, oral infections, and STIs

  • Well-suited for prophylaxis and treatment of congenital toxoplasmosis

  • Generally well-tolerated with low risk of drug interactions

  • Manufactured by BAGRX PHARMACEUTICALS under the SPIRABAG™ brand

Quick view

CIROFEM-D3 Oral Solution

CIROFEM-D3 is a ready-to-drink Vitamin D3 Oral Solution I.P. containing 60,000 I.U. of cholecalciferol per 5 ml bottle. Presented in a convenient 4 x 5 ml bottle pack, it ensures precise dosing and rapid improvement of Vitamin D3 levels. Indicated for the prevention and treatment of Vitamin D deficiency, osteoporosis, rickets, and osteomalacia. Manufactured by BAGRX PHARMACEUTICALS, CIROFEM-D3 offers high bioavailability, excellent tolerability, and patient-friendly ready-to-use format.
Quick view

STOP-CR-15 Tablets

STOP-CR-15 contains Norethisterone Controlled Release Tablets I.P. 15 mg, a potent synthetic progestogen designed for controlled release over an extended period. Each strip contains 10 x 5 tablets, offering convenience and precise dosing. Indicated for the management of dysfunctional uterine bleeding, endometriosis, menstrual disorders, and postponement of menstruation. Manufactured by FEMiNA, STOP-CR-15 ensures consistent therapeutic effect with enhanced patient compliance.
Quick view

DYDROBIG Tablets

DYDROBIG contains Dydrogesterone Tablets I.P. 10 mg, an orally active progestogen that is structurally and pharmacologically similar to natural progesterone. Each pack contains 10 x 1 x 10 tablets (100 tablets total), ensuring ease of dispensing and long-term therapy support. Indicated for luteal phase support, endometriosis, threatened abortion, recurrent pregnancy loss, and various menstrual cycle disorders. Manufactured by FEMiNA, DYDROBIG offers reliable efficacy with minimal androgenic and metabolic side effects.